Zu "138926-19-9" wurden 3 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
Ibandronate sodium monohydrate
Artikelnummer: TGM-T6539-100mg
Description: Ibandronate sodium monohydrate (BM-210955) is a highly potent nitrogen-containing bisphosphonate used for the treatment of osteoporosis. Target: Others, Apoptosis. Smiles: O.[Na+].CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)([O-])=O. References: Morgan C, et al. Microvasc Res, 2009, 78(3), 453-458.
| Schlagworte: | RPR-102289A, BM-21.0955, BM-210955, Bondronat monohydrate, Ibandronate sodium, Boniva monohydrate |
| Anwendung: | Targets farnesyl diphosphate synthase [EC:2.5.1.1 2.5.1.10] (FDPS) |
| CAS | 138926-19-9 |
| MW: | 359.23 D |
ab 31,00 €
Ibandronate (sodium hydrate)
Artikelnummer: Cay21361-25
Ibandronate is a bisphosphonate that has been used in formulations for the treatment of osteoporosis. It binds to hydroxyapatite crystals with an affinity constant of 2.36 µM, inhibiting their growth and bone resorption.Formal Name: P,P'-[1-hydroxy-3-(methylpentylamino)propylidene]bis-phosphonic acid, monosodium...
| Schlagworte: | P,P'-[1-hydroxy-3-(methylpentylamino)propylidene]bis-phosphonic acid, monosodium salt, monohydrate |
| Anwendung: | Bisphosphonate, osteoporosis agent, FDPS inhibitor |
| CAS | 138926-19-9 |
| MW: | 359.2 D |
ab 55,00 €
Ibandronate Sodium Monohydrate
Artikelnummer: LKT-I0502.10
Bisphosphonate.
| Schlagworte: | Ibandronic acid sodium salt, [1-Hydroxy-3-(methylpentylamino)propylidene]bis- phosphonic acid |
| Anwendung: | Farnesylpyrophosphate synthetase inhibitor |
| CAS | 138926-19-9 |
| MW: | 359.21 D |
ab 177,00 €
